N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.65p
   
  • Change Today:
    -0.025p
  • 52 Week High: 3.07
  • 52 Week Low: 0.60
  • Currency: UK Pounds
  • Shares Issued: 268.78m
  • Volume: 1,668,891
  • Market Cap: £1.75m

Deal with Barclays    Trade now with Barclays Stockbrokers

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
30-Jun-23 Interim n/a (0.65) (0.28)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 0.07 (1.39) (1.32)p n/a n/a n/a n/a 0.0%
31-Dec-19 n/a (0.95) (0.87)p n/a n/a n/a n/a 0.0%
31-Dec-20 n/a (1.57) (0.96)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (1.84) (0.85)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (1.19) (0.55)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Forecasts data is not available for this company.

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

N4 Pharma Market Data

Currency UK Pounds
Share Price 0.65p
Change Today -0.025p
% Change -3.70 %
52 Week High 3.07
52 Week Low 0.60
Volume 1,668,891
Shares Issued 268.78m
Market Cap £1.75m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
5.84% above the market average5.84% above the market average5.84% above the market average5.84% above the market average5.84% above the market average
14.81% below the sector average14.81% below the sector average14.81% below the sector average14.81% below the sector average14.81% below the sector average
Value
5.84% above the market average5.84% above the market average5.84% above the market average5.84% above the market average5.84% above the market average
14.81% below the sector average14.81% below the sector average14.81% below the sector average14.81% below the sector average14.81% below the sector average
Income Not Available
Growth Not Available

N4 Pharma Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
16:20 1,428 @ 0.70p
16:20 344,883 @ 0.64p
16:14 160,623 @ 0.64p
15:46 1,000 @ 0.60p
15:40 700 @ 0.60p

N4 Pharma Key Personnel

CEO Nigel Theobald

Top of Page